The gazette notification appoints Dr. Rajeev Singh Raghuvanshi, Drugs Controller (India), Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare, as the Licensing Authority.
This appointment is made in pursuance of clause (b) of rule 21 of the Drugs and Cosmetics Rules, 1945.
Key Changes
Dr. Rajeev Singh Raghuvanshi is appointed as the Licensing Authority.
The appointment is effective until Dr. Raghuvanshi reaches the age of superannuation on February 28, 2025, or until further orders, whichever is earlier.
Impact Analysis
Impact on CDSCO
The organization should prepare for a transition in leadership of the Licensing Authority role on or before February 28, 2025.
Impact on Pharmaceutical Companies
Companies should monitor for any further notifications or orders that may affect the tenure or responsibilities of the Licensing Authority.
Suggested Action Items
Monitor official notifications for any changes to the tenure or responsibilities of the Licensing Authority.
Key Entities Referenced
Dr. Rajeev Singh Raghuvanshi: Drugs Controller (India), Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Appointed as Licensing Authority.
Central Drugs Standard Control Organisation (CDSCO): The national regulatory body for Indian pharmaceuticals and medical devices. It is responsible for drug approval, setting standards, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations.
Ministry of Health and Family Welfare: The government ministry responsible for health policy in India.
Drugs and Cosmetics Rules, 1945: A set of rules and regulations governing the import, manufacture, distribution, and sale of drugs and cosmetics in India.
Licensing Authority: The authority responsible for granting licenses related to drugs and cosmetics as per the Drugs and Cosmetics Rules, 1945.
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99
सी.जी.-डी.एल.-अ.-28022023-243956
xxxGIDHxxx
CG-DL-E-28022023-243956
xxxGIDExxx
असाधारण
EXTRAORDINARY
भाग II—खण् ड 3—उप-खण्ड (ii)
PART II—Section 3—Sub-section (ii)
प्राजधकार स ेप्रकाजित
PUBLISHED BY AUTHORITY
स.ं 861] िई दिल्ली, मगं लवार, फरवरी 28, 2023/फाल्ग िु 9, 1944
No. 861] NEW DELHI, TUESDAY, FEBRUARY 28, 2023/PHALGUNA 9, 1944
स्ट्वास्ट््य और पररवार कल्याण मंत्रालय
(स्ट्वास्ट््य और पररवार कल्याण जवभाग)
(औषजध जवजियमि अिभु ाग)
अजधसचू िा
िई दिल्ली, 28 फरवरी, 2023
का.आ. 898(अ).—औषध और प्रसाधि सामग्री जियम, 1945 के जियम 21 के खंड (ख) के उपबंधों के
अिुसरण में केन्द्र सरकार, एतद्द्वारा डॉ. रािीव ससह रघुवंिी, भारत के औषध जियंत्रक, केन्द्रीय औषध मािक
जियंत्रण संगठि, स्ट्वास्ट््य और पररवार कल्याण मंत्रालय को 28.02.2025 को उिकी अजधवर्षषता की आयु प्राप्त
करिे तक या अगले आििे तक, इसम ें से िो भी पहले हो, लाइसेंजसग प्राजधकारी जियक्तु करती ह ै
[फा. सं. ए-12025/03/2022–डीआरएस]
एस. गोपालकृष्णि, जविेष सजचव
1291 GI/2023 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
MINISTRY OF HEALTH AND FAMILY WELFARE
(DEPARTMENT OF HEALTH AND FAMILY WELFARE)
(Drugs Regulation Section)
NOTIFICATION
New Delhi, the 28th February, 2023
S.O. 898(E).—In pursuance of the provisions of clause (b) of rule 21 of the Drugs and Cosmetics
Rules, 1945, the Central Government hereby appoints Dr. Rajeev Singh Raghuvanshi, Drugs Controller
(India), Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare to be the
Licensing Authority till his attaining the age of superannuation on 28.02.2025, or until further orders,
whichever is earlier.
[F. No. A.12025/03/2022-DRS]
S. GOPALAKRISHNAN, Special Secy.
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.